{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:45Z","timestamp":1787020845216,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13052-016-0291-2","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T23:05:32Z","timestamp":1473116732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Beh\u00e7et disease responding to adalimumab: a case report"],"prefix":"10.1186","volume":"42","author":[{"given":"Manuela","family":"Marsili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Marzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lucantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lapergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"key":"291_CR1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/rheumatology\/ket009","volume":"52","author":"T Mijovic","year":"2013","unstructured":"Mijovic T, Zeitouni A, Colmegna I. Autoimmune sensorineural hearing loss: the otology-rheumatology interface. Rheumatology. 2013;52:780\u201389.","journal-title":"Rheumatology"},{"key":"291_CR2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ijporl.2007.03.017","volume":"71","author":"AO Ikiz","year":"2007","unstructured":"Ikiz AO, Unsal E, Kirkim G, Erdaq TK, Guneri EA. Hearing loss and middle ear involvement in patients with juvenile idiopathic arthritis. Int J Pediatr Otorinolaryngol. 2007;71:1079\u201385.","journal-title":"Int J Pediatr Otorinolaryngol"},{"key":"291_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Beh\u00e7et's Disease (ITR- ICBD)","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et's Disease (ITR- ICBD). The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338\u201347.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"291_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1610-0387.2006.05841.x","volume":"4","author":"A Alterburg","year":"2006","unstructured":"Alterburg A, Papoustis N, Orawa H, Martus P, Krause L, Zouboulis CC. Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany-current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges. 2006;4(1):49\u201364.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"291_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/09273948.2011.634978","volume":"20","author":"A Gul","year":"2012","unstructured":"Gul A, Ohno S. HLA-B*51 and Beh\u00e7et Disease. Ocul Immunol Inflamm. 2012;20(1):37\u201343.","journal-title":"Ocul Immunol Inflamm"},{"key":"291_CR6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.50.6.351","volume":"50","author":"N Arber","year":"1991","unstructured":"Arber N, Klein T, Meiner Z, Pras E, Weinberger A. Close association of HLA-B51 and B52 in Israeli patients with Beh\u00e7et's syndrome. Ann Rheum Dis. 1991;50:351\u20133.","journal-title":"Ann Rheum Dis"},{"key":"291_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.otorri.2013.06.007","volume":"65","author":"C Morales-Angulo","year":"2014","unstructured":"Morales-Angulo C, Vergara Pastrana S, Obeso-Ag\u00fcera S, Acle L, Gonz\u00e1lez-Gay M\u00c1. Otorhinolaryngological manifestations in patients with Beh\u00e7et disease. Acta Otorrinolaringol Esp. 2014;65:15\u201321.","journal-title":"Acta Otorrinolaringol Esp"},{"key":"291_CR8","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et's Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et's Disease. Criteria for diagnosis of Behcet Disease. Lancet. 1990;335:1078\u201380.","journal-title":"Lancet"},{"key":"291_CR9","doi-asserted-by":"crossref","unstructured":"Kon\u00e9-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, et al. Consensus classification criteria for paediatric Beh\u00e7et's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2015 Dec;23 [Epub ahead of print].","DOI":"10.1136\/annrheumdis-2015-208491"},{"issue":"10","key":"291_CR10","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/ard.2008.087957","volume":"68","author":"G Hatemi","year":"2009","unstructured":"Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. Management of Beh\u00e7et dysease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Beh\u00e7et disease. Ann Rheum Dis. 2009;68(10):1528\u201334.","journal-title":"Ann Rheum Dis"},{"key":"291_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09629350220131935","volume":"11","author":"C Evereklioglu","year":"2002","unstructured":"Evereklioglu C, Er H, T\u00fcrk\u00f6z Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet\u2019s disease. Mediators Inflamm. 2002;11:87\u201393.","journal-title":"Mediators Inflamm"},{"key":"291_CR12","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/rheumatology\/kes130","volume":"51","author":"D Perra","year":"2012","unstructured":"Perra D, Alba MA, Callejas JL, et al. Adalimumab for the treatment of Beh\u00e7et's disease: experience in 19 patients. Rheumatology (Oxford). 2012;51:1825\u201331.","journal-title":"Rheumatology (Oxford)"},{"key":"291_CR13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","volume":"62","author":"H Vallet","year":"2015","unstructured":"Vallet H, Riviere S, Sanna A, et al. Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et's disease: Multicenter study of 124 patients. J Autoimmun. 2015;62:67\u201374.","journal-title":"J Autoimmun"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-016-0291-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:26:46Z","timestamp":1568341606000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-016-0291-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["291"],"URL":"https:\/\/doi.org\/10.1186\/s13052-016-0291-2","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]},"article-number":"81"}}